Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 15/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | CLK4 | Q9HAZ1 | 5/20 | 0.70 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16997374 | 0.88 | PDE5A (0.78) | PDE5AALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL7499068 | 0.87 | PDE5A (1.00) | PDE5AALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL7548083 | 0.87 | PDE5A (0.80) | PDE5AALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL7495950 | 0.84 | PDE5A (1.00) | PDE5AALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL31034788 | 0.84 | PDE5A (1.00) | PDE5AALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL8015683 | 0.84 | PDE5A (1.00) | PDE5AALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL2458882 | 0.84 | PDE5A (1.00) | PDE5AALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL31038289 | 0.84 | PDE5A (1.00) | PDE5AALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL13191863 | 0.84 | PDE5A (0.76) | PDE5AALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL13192079 | 0.84 | PDE5A (0.76) | PDE5AALDH1A1MEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9447081-B2 | Substituted pyrimidines as pharmaceuticals and insecticides | SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) | 2016-09-20 | — | — | US | disclosed |
| US-20150225378-A1 | HOMOPIPERONY LAMINE COMPOUND AND USE THEREOF | SINOCHEM CORPORATION (CN) | 2015-08-13 | — | — | US | disclosed |
| US-8309133-B2 | Nanoparticulate quinazoline derivative formulations | ALKERMES PHARMA IRELAND LIMITED (IE) | 2012-11-13 | — | — | US | disclosed |
| EP-1871345-B1 | NANOPARTICULATE ERLOTINIB FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2012-08-01 | — | — | EP | disclosed |
| EP-1871345-A1 | NANOPARTICULATE QUINAZOLINE DERIVATIVE FORMULATIONS | Elan Pharma International Limited (IE) | 2008-01-02 | — | — | EP | disclosed |
| US-20060246142-A1 | Nanoparticulate quinazoline derivative formulations | ELAN PHARMA INTERNATIONAL, LIMITED | 2006-11-02 | — | — | US | disclosed |
| WO-2006110811-A1 | NANOPARTICULATE QUINAZOLINE DERIVATIVE FORMULATIONS | ELAN PHARMA INTERNATIONAL LIMITED (IE) | 2006-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246142-A1 | Nanoparticulate quinazoline derivative formulations | KRAS, NRAS, ABL1 | PDE5A 2373/4885ALDH1A1 2763/4885MEN1 814/4885 |
| US-20150225378-A1 | HOMOPIPERONY LAMINE COMPOUND AND USE THEREOF | CLPP, LRRK2, MYB | PDE5A 270/4885ALDH1A1 3907/4885MEN1 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.